Metabolic Complications: Update From Los Angeles

Faculty:

Judith S. Currier, MD, MSc Joseph J. Eron, Jr., MD Joel E. Gallant, MD, MPH

Sally Hodder, MD Donald P. Kotler, MD William G. Powderly, MD

Kimberly Y. Smith, MD, MPH Andrew R. Zolopa, MD

Learning Objectives

Upon completion of this activity, participants should be able to:

• Describe observations about the natural history of HIV infection and the development of metabolic complications
• Specify data on metabolic complications observed in recent studies of approved and investigational antiretroviral agents
• Discuss recent insights into the management and prevention of metabolic complications in HIV-infected patients

Topics covered include:

• Natural History of HIV and Metabolic Events
• Effects of Antretroviral Therapy on Fat Redistribution, Lipids, Cardiovascular Disease, and Renal Function
• Treatment Interruption and Cardiovascular Events
• Effects of Exogenous Treatments on Bone, Visceral Fat, and Lipids in HIV-Infected Patients